Literature DB >> 27476888

Defective natural killer cell activity in a mouse model of eczema herpeticum.

Yuko Kawakami1, Tomoaki Ando2, Jong-Rok Lee1, Gisen Kim3, Yu Kawakami1, Tae Nakasaki1, Manando Nakasaki1, Kenji Matsumoto4, Youn Soo Choi5, Toshiaki Kawakami6.   

Abstract

BACKGROUND: Patients with atopic dermatitis (AD) are susceptible to several viruses, including herpes simplex virus (HSV). Some patients experience 1 or more episodes of a severe skin infection caused by HSV termed eczema herpeticum (EH). There are numerous mouse models of AD, but no established model exists for EH.
OBJECTIVE: We sought to establish and characterize a mouse model of EH.
METHODS: We infected AD-like skin lesions with HSV1 to induce severe skin lesions in a dermatitis-prone mouse strain of NC/Nga. Gene expression was investigated by using a microarray and quantitative PCR; antibody titers were measured by means of ELISA; and natural killer (NK) cell, cytotoxic T-cell, regulatory T-cell, and follicular helper T-cell populations were evaluated by using flow cytometry. The role of NK cells in HSV1-induced development of severe skin lesions was examined by means of depletion and adoptive transfer.
RESULTS: Inoculation of HSV1 induced severe erosive skin lesions in eczematous mice, which had an impaired skin barrier, but milder lesions in small numbers of normal mice. Eczematous mice exhibited lower NK cell activity but similar cytotoxic T-cell activity and humoral immune responses compared with normal mice. The role of NK cells in controlling HSV1-induced skin lesions was demonstrated by experiments depleting or transferring NK cells.
CONCLUSION: A murine model of EH with an impaired skin barrier was established in this study. We demonstrated a critical role of defective NK activities in the development of HSV1-induced severe skin lesions in eczematous mice.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. All rights reserved.

Entities:  

Keywords:  Atopic dermatitis; animal model; eczema herpeticum; herpes simplex virus; natural killer cell

Mesh:

Substances:

Year:  2016        PMID: 27476888      PMCID: PMC5276800          DOI: 10.1016/j.jaci.2016.06.034

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  54 in total

1.  Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma.

Authors:  Sayo Kataoka; Yuko Konishi; Youhei Nishio; Kiyomi Fujikawa-Adachi; Akira Tominaga
Journal:  DNA Cell Biol       Date:  2004-09       Impact factor: 3.311

2.  IL-29/IL-28A suppress HSV-1 infection of human NT2-N neurons.

Authors:  Lin Zhou; Jieliang Li; Xu Wang; Li Ye; Wei Hou; Jie Ho; He Li; Wenzhe Ho
Journal:  J Neurovirol       Date:  2011-04-16       Impact factor: 2.643

3.  NK cell-depleting anti-asialo GM1 antibody exhibits a lethal off-target effect on basophils in vivo.

Authors:  Hideto Nishikado; Kaori Mukai; Yohei Kawano; Yoshiyuki Minegishi; Hajime Karasuyama
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

4.  Circulating Foxp3+CD4+ cell numbers in atopic patients and healthy control subjects.

Authors:  Kanami Orihara; Masami Narita; Takashi Tobe; Akira Akasawa; Yukihiro Ohya; Kenji Matsumoto; Hirohisa Saito
Journal:  J Allergy Clin Immunol       Date:  2007-07-12       Impact factor: 10.793

Review 5.  Increased susceptibility to cutaneous viral infections in atopic dermatitis: the roles of regulatory T cells and innate immune defects.

Authors:  Tetsuo Shiohara; Yohei Sato; Ryo Takahashi; Maiko Kurata; Yoshiko Mizukawa
Journal:  Curr Probl Dermatol       Date:  2011-05-12

6.  Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice.

Authors:  J M Spergel; E Mizoguchi; J P Brewer; T R Martin; A K Bhan; R S Geha
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

7.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

8.  CTL are inactivated by herpes simplex virus-infected cells expressing a viral protein kinase.

Authors:  Derek D Sloan; George Zahariadis; Christine M Posavad; Nichlos T Pate; Steven J Kussick; Keith R Jerome
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

9.  Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs.

Authors:  Richard Brans; Feng Yao
Journal:  BMC Microbiol       Date:  2010-06-03       Impact factor: 3.605

10.  Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum.

Authors:  Yuko Kawakami; Yoshiaki Tomimori; Kenji Yumoto; Shunji Hasegawa; Tomoaki Ando; Yutaka Tagaya; Shane Crotty; Toshiaki Kawakami
Journal:  J Exp Med       Date:  2009-05-25       Impact factor: 14.307

View more
  3 in total

Review 1.  The Genetics of Eczema Herpeticum.

Authors:  Elisabeth Hodara; Peck Y Ong
Journal:  Clin Rev Allergy Immunol       Date:  2022-09-17       Impact factor: 10.817

Review 2.  Mechanisms of Immune Control of Mucosal HSV Infection: A Guide to Rational Vaccine Design.

Authors:  Naomi R Truong; Jacinta B Smith; Kerrie J Sandgren; Anthony L Cunningham
Journal:  Front Immunol       Date:  2019-03-06       Impact factor: 7.561

Review 3.  Th1 regulatory events by infectious pathogens, herpes zoster and herpes simplex viruses: prospects for therapeutic options for atopic eczema.

Authors:  Yasuhiro Horiuchi
Journal:  Postepy Dermatol Alergol       Date:  2022-09-01       Impact factor: 1.664

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.